Literature DB >> 17652478

Testing of diagnostic methods for detection of influenza virus for optimal performance in the context of an influenza surveillance network.

Mercedes Pérez-Ruiz1, Ruth Yeste, María-José Ruiz-Pérez, Alfonso Ruiz-Bravo, Manuel de la Rosa-Fraile, José María Navarro-Marí.   

Abstract

Influenza surveillance networks must detect early the viruses that will cause the forthcoming annual epidemics and isolate the strains for further characterization. We obtained the highest sensitivity (95.4%) with a diagnostic tool that combined a shell-vial assay and reverse transcription-PCR on cell culture supernatants at 48 h, and indeed, recovered the strain.

Entities:  

Mesh:

Year:  2007        PMID: 17652478      PMCID: PMC2045238          DOI: 10.1128/JCM.00697-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Rapid detection of respiratory viruses by shell vial assay using simultaneous culture of HEp-2, LLC-MK2, and MDCK cells in a single vial.

Authors:  J M Navarro-Marí; S Sanbonmatsu-Gámez; M Pérez-Ruiz; M De La Rosa-Fraile
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

Review 2.  Molecular diagnosis of influenza.

Authors:  Joanna S Ellis; Maria C Zambon
Journal:  Rev Med Virol       Date:  2002 Nov-Dec       Impact factor: 6.989

3.  Comparison of the Denka-Seiken INFLU A.B-Quick and BD Directigen Flu A+B kits with direct fluorescent-antibody staining and shell vial culture methods for rapid detection of influenza viruses.

Authors:  James J Dunn; Chris Gordon; Christy Kelley; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

4.  Detection of human adenoviruses and enteroviruses in Korean oysters using cell culture, integrated cell culture-PCR, and direct PCR.

Authors:  Yoe-Jin Choo; Sang-Jong Kim
Journal:  J Microbiol       Date:  2006-04       Impact factor: 3.422

5.  Evaluation of a rapid optical immunoassay for influenza viruses (FLU OIA test) in comparison with cell culture and reverse transcription-PCR.

Authors:  G Boivin; I Hardy; A Kress
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  Simultaneous detection and typing of influenza viruses A and B by a nested reverse transcription-PCR: comparison to virus isolation and antigen detection by immunofluorescence and optical immunoassay (FLU OIA).

Authors:  B Herrmann; C Larsson; B W Zweygberg
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

7.  Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses.

Authors:  J Stockton; J S Ellis; M Saville; J P Clewley; M C Zambon
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

8.  Detection of human metapneumovirus antigens in nasopharyngeal secretions by an immunofluorescent-antibody test.

Authors:  Takashi Ebihara; Rika Endo; Xiaoming Ma; Nobuhisa Ishiguro; Hideaki Kikuta
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

  8 in total
  4 in total

1.  Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups.

Authors:  Eva van Doorn; Maryam Darvishian; Frederika Dijkstra; Gé A Donker; Pieter Overduin; Adam Meijer; Eelko Hak
Journal:  Vaccine       Date:  2017-04-12       Impact factor: 3.641

2.  Laboratory detection of respiratory viruses by automated techniques.

Authors:  Mercedes Pérez-Ruiz; Irene Pedrosa-Corral; Sara Sanbonmatsu-Gámez; María Navarro-Marí
Journal:  Open Virol J       Date:  2012-11-30

3.  Association of Human bocavirus with Respiratory Infections in Outpatients and in Patients Attended at a Reference Hospital.

Authors:  Irene Pedrosa-Corral; Mercedes Pérez-Ruiz; José-María Navarro-Marí; Alfonso Ruiz-Bravo
Journal:  Indian J Virol       Date:  2011-07-15

Review 4.  Diagnostic testing or empirical therapy for patients hospitalized with suspected influenza: what to do?

Authors:  Allison J McGeer
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.